UPC Stock Analysis: Buy, Sell, or Hold?
UPC - Universe Pharmaceuticals Inc. Ordinary Shares
$4.36
0.48 (12.37%)
▲
5d:
+0.69%
30d:
-28.05%
90d:
+34.15%
WAIT
LOW Confidence
Analysis Updated: Sep 11, 2026 12:00 AM ET
Earnings: Apr 22, 2026
0d
Get Alerted When UPC Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 MIXED SIGNALS: UPC shows conflicting indicators. Wait for confirmation before entering.
📊 MIXED SIGNALS: UPC shows conflicting indicators. Wait for confirmation before entering.
In-depth Analysis How we analyze
Valuation Analysis: UPC is currently trading at $4.36, which is considered oversold relative to its 30-day fair value range of $4.40 to $5.95.
Technical Outlook: Technically, UPC is in a uptrend. Immediate support is located at $3.77, while resistance sits at $5.55. The stock is showing strong short-term momentum, up 12.4% recently.
Market Sentiment: The stock scores a mixed 40/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, UPC is in a uptrend. Immediate support is located at $3.77, while resistance sits at $5.55. The stock is showing strong short-term momentum, up 12.4% recently.
Market Sentiment: The stock scores a mixed 40/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$4.40 -
$5.95
Company Quality Score
49/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
86.5%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+12.4%)
- WARNING: Composite score 49/100 in the bottom quintile — this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$4.40 -
$5.95
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$3.77
Resistance Level
$5.55
Current Trend
Uptrend
Technical data as of
Sep 11, 2026
Fundamental Context
Revenue Growth (YoY)
-1.3%
Earnings Growth (YoY)
-82.0%
Profit Margin
-10.9%
Share & Embed Analysis
Last updated: September 13, 2026 8:51 AM ET
Data refreshes hourly during market hours. Next update: 9:51 AM
Data refreshes hourly during market hours. Next update: 9:51 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is UPC showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Drug Manufacturers - Specialty & Generic Stocks
Top-rated stocks in Drug Manufacturers - Specialty & Generic by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NBIX
Neurocrine Biosciences I… |
STRONG BUY
25 analysts |
$212 | 60 HOLD |
|
LQDA
Liquidia Technologies Inc |
STRONG BUY
10 analysts |
$108 | 70 BUY |
|
INDV
Indivior PLC Ordinary Sh… |
STRONG BUY
7 analysts |
$49 | 69 BUY |
|
LNTH
Lantheus Holdings Inc |
STRONG BUY
13 analysts |
$108 | 46 HOLD |
|
UTHR
United Therapeutics Corp… |
STRONG BUY
15 analysts |
$664 | 47 HOLD |
